HI
EW icon

HBK Investments’s Edwards Lifesciences EW Stock Holding History

HBK Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,500
Closed -$599K – 712
2020
Q3 		$599K Hold
7,500
– – ﹤0.01% 504
2020
Q2 		$518K Buy
+7,500
New +$533K 0.01% 452
2020
Q1 		– Sell
-32,700
Closed -$2.54M – 188
2019
Q4 		$2.54M Buy
32,700
+4,200
+15% +$328K 0.02% 387
2019
Q3 		$2.09M Buy
+28,500
New +$2M 0.03% 391

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

HBK Investments's EW Position: Q1 2018 in Review

HBK Investments sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 141,300 shares — an estimated $5.31M sold.

HBK Investments first reported a position in EW in Q3 2014 and held it in 10 quarters. The position peaked at $15.6M in Q2 2016. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

  • HBK Investments reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
  • HBK Investments sold 141,300 Edwards Lifesciences shares in Q1 2018, an estimated $5.31M.
  • HBK Investments first reported a position in Edwards Lifesciences in Q3 2014 and held it in 10 quarters.
  • HBK Investments's Edwards Lifesciences position peaked at $15.6M in Q2 2016.
  • 815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on HBK Investments's 13F filing for Q1 2018, filed 15 May 2018.